Regulators halt Sun Pharma eye-drug output at Assam plant

Indian drug regulators ordered Sun Pharmaceutical Industries to stop making, selling and distributing ophthalmic products from its Assam facility after finding failures in its quality management system, according to documents reviewed by Reuters. The CDSCO and Assam's drugs controller issued the order on August 20 following a joint inspection, after Sun Pharma voluntarily recalled about 11 eye-care brands in July.